A Morrisons distribution center employee has been diagnosed with meningitis after visiting Club Chemistry in Canterbury. This incident is part of a larger outbreak in Kent, with seven new cases reported, bringing the total number of confirmed and suspected cases to 27. The affected individual works at the Sittingbourne distribution center, and the specific strain of meningitis has not been identified yet.
According to a spokesperson from Morrisons, the infected employee is currently receiving treatment, and the company is in close contact with the individual’s family. The distribution center is following government guidelines, operating normally, and closely monitoring the situation.
The UK Health Security Agency (UKHSA) reported that, as of March 18, there were 15 confirmed cases of meningitis in laboratories, with 12 more cases under investigation. Two deaths have occurred due to the outbreak, but there have been no additional fatalities since the last update. A total of 600 meningitis B vaccines were distributed at the University of Kent.
Students are lining up outside the campus sports center to receive their vaccinations. Trish Mannes, the UKHSA regional deputy director for the South East, emphasized the importance of receiving two doses of the MenB vaccine for protection against meningococcal B disease. However, the vaccine does not safeguard against all strains of meningococcal disease or prevent the bacteria from spreading in the community.
It is crucial for individuals to be aware of the signs and symptoms of invasive meningococcal disease and seek immediate medical attention if they or someone they know exhibit these symptoms. Those offered preventive antibiotics should take them promptly. Students who are eligible for the vaccine but have left the university campus should contact their local GP for advice and treatment options.